My name is Russell Winwood; I’m 59 years old and have been living with severe COPD for the past 14 years. Nowadays I live very well with my COPD, but it hasn’t always been like this.

Point-of-care testing of C-reactive protein (CRP) for the acute assessment of worsening symptoms in people known to have COPD can safely reduce the use of antibiotics and could help improve the diagnostic approach towards someone presenting in such a crisis.

Alpha-1 antitrypsin deficiency (AATD) is a hereditary condition caused by one of many mutations in the SERPINA1 gene, resulting in reduced levels or absence of the alpha-1 antitrypsin (AAT) protein.

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition that remains a major cause of morbidity and mortality worldwide.

PCRS advocates that: 

In this article the authors review current evidence and guidance for the treatment of Chronic obstructive pulmonary disease (COPD) to bring up to date the Primary Care Respiratory Society (PCRS) consensus approach and algorithm first published in 2017 and then again in 2023 known as ‘Keeping it S

Winter brings predictable surges in respiratory illness and pressure across urgent and emergency care. This paper sets out a practical, primary care-led framework to reduce avoidable demand by acting earlier on respiratory risk. We describe seven interventions:

The autumn/winter edition of your members’ magazine packed with useful features, clinical updates, educational updates, respiratory news and opinion.

This summary infographic provides an overview of the new MART therapy which has been licensed for children of 6 - 11 years old.

World COPD Day, this year taking place on the 19th November, is an annual global initiative run by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). World COPD Day aims to raise awareness and present new knowledge and novel therapeutic strategies for COPD worldwide.

The BTS/NICE/SIGN asthma guidelines now recommend moving away from blue (reliever) and brown (preventer) inhalers. Many people with asthma still rely on their blue inhaler despite the fact they:

We are pleased to launch a new series of resources on health inequalities, which bring you everything you need to know about caring for people with respiratory disease who are impacted by health inequalities and severe mental illness.

In this PCRS Health Inequalities podcast Leslie Borrill and Rebecca Jacobs discuss suicide and suicide prevention in long-term respiratory conditions. They cover:

In this PCRS Health Inequalities podcast Noreen Grant, Lisa Cummings and Aaron Foulds (PCRS patient reference group representative) talk about the impact of respiratory disease on mental health. They cover:

In this PCRS Health Inequalities podcast Katherine Hickman (PCRS executive chair, Kaniksha Aggarwal, Martin Sutcliffe and Sue Wheatcroft discuss respiratory disease and mental health in the context of the UK prison setting. They touch on: